J Fleminger
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial
Fleminger, J; Seed, PT; Smith, A; Dixon, PH; Juszczak, E; Chambers, J; Dorling, J; Williamson, C; Thornton, JG; Chappell, LC
Authors
PT Seed
A Smith
PH Dixon
Professor ED JUSZCZAK ED.JUSZCZAK@NOTTINGHAM.AC.UK
PROFESSOR OF CLINICAL TRIALS AND STATISTICS IN MEDICINE
J Chambers
J Dorling
C Williamson
JG Thornton
LC Chappell
Abstract
Objective: To evaluate whether a particular group of women with intrahepatic cholestasis of pregnancy (ICP), based on their presenting characteristics, would benefit from treatment with ursodeoxycholic acid (UDCA). Design: Secondary analysis of the PITCHES trial (ISRCTN91918806). Setting: United Kingdom. Population or Sample: 527 women with ICP. Methods: Subgroup analyses were performed to determine whether baseline bile acid concentrations or baseline itch scores moderated a woman’s response to treatment with UDCA. Main outcome measures: Bile acid concentration and itch score. Results: In women with baseline bile acid concentrations less than 40μmol/l, treatment with UDCA resulted in increased post-randomisation bile acid concentrations (geometric mean ratio 1.19, 95% CI 1.00–1.41, P=0.048). A test of interaction showed no significance (P=0.647). A small, clinically insignificant difference was seen in itch response in women with a high baseline itch score (–6.0mm, 95% CI −11.80 to −0.21, P=0.042), with a test of interaction not showing significance (P=0.640). Further subgroup analyses showed no significance. Across all women there was a weak relationship between bile acid concentrations and itch severity. Conclusions: There was no subgroup of women with ICP in whom a beneficial effect of treatment with UDCA on bile acid concentration or itch score could be identified. This confirms that its routine use in women with this condition for improvement of bile acid concentration or itch score should be reconsidered. Tweetable abstract: PITCHES: No group of women with ICP has been found in whom UDCA reduces bile acid concentrations or pruritus.
Citation
Fleminger, J., Seed, P., Smith, A., Dixon, P., Juszczak, E., Chambers, J., Dorling, J., Williamson, C., Thornton, J., & Chappell, L. (2021). Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial. BJOG: An International Journal of Obstetrics and Gynaecology, 128(6), 1066-1075. https://doi.org/10.1111/1471-0528.16567
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 8, 2020 |
Online Publication Date | Oct 16, 2020 |
Publication Date | 2021-05 |
Deposit Date | Feb 8, 2023 |
Publicly Available Date | Feb 14, 2023 |
Journal | BJOG: An International Journal of Obstetrics and Gynaecology |
Print ISSN | 1470-0328 |
Electronic ISSN | 1471-0528 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 128 |
Issue | 6 |
Pages | 1066-1075 |
DOI | https://doi.org/10.1111/1471-0528.16567 |
Keywords | Obstetrics and Gynaecology |
Public URL | https://nottingham-repository.worktribe.com/output/4974160 |
Publisher URL | https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.16567 |
Files
Ursodeoxycholic acid in intrahepatic cholestasisof pregnancy: a secondary analysis of thePITCHES trial
(2 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement
(2023)
Journal Article